EXCLUSIVE: Two brothers were shocked when diagnosed with prostate cancer within a month of each other. But luckily that ...

Louis van Gaal has said he is "no longer bothered by cancer" and is keen for a return to the higher levels of the game.

During a live event, Jahan Aghalar, MD, discussed key NCCN-recommended oral therapies and landmark trials for metastatic ...

New research in the July 2025 issue of JNCCN-Journal of the National Comprehensive Cancer Network finds that for people diagnosed with nonmetastatic low-risk prostate cancer later in life, and treated ...

Discover a study comparing ultrasound and CBCT for bladder monitoring in prostate cancer radiotherapy to improve accuracy and ...

An expert discusses how CT scans and bone scans remain the standard imaging approach for most patients with metastatic castration-resistant prostate cancer (mCRPC), whereas prostate-specific membrane ...

Pfizer and Astellas’ Xtandi (enzalutamide) has improved overall survival (OS) in patients with non-metastatic hormone-sensitive prostate cancer (nmHSPC), but only as a combination therapy.

Xtandi plus leuprolide improved overall survival in prostate cancer patients in the Phase 3 EMBARK trial, with no new safety ...

Men with non-metastatic forms are likely to live 'for many years' after diagnosis when active surveillance and other NCCN ...

Real-world data suggest that Erleada may offer an advantage over other treatment options for patients with metastatic ...

“Personalizing treatment in this way may lessen harmful side effects, reduce damage to healthy cells and make it more likely ...

Breast cancer is the most commonly diagnosed cancer among women worldwide and represents a major public health concern due to ...